| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |